Home> Products> tailored benefits

{ "products": [ { "_id": "6958dbfa1063d98b1e8f2fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benidipine 4mg", "description": "BENIPRIME 4, containing Benidipine 4 mg, offers effective management for high blood pressure and related heart conditions. This calcium channel blocker helps relax blood vessels to improve blood flow and reduce strain on the heart. Patients often find it reliable for daily control of hypertension symptoms.\n\nWhat is BENIPRIME 4?\nBENIPRIME 4 is a branded tablet from Steris Healthcare Pvt Ltd, featuring 4 mg of Benidipine as the active ingredient. Benidipine belongs to the dihydropyridine class of calcium channel blockers, designed specifically for cardiovascular health. Each tablet delivers a precise dose in a user-friendly form, typically packaged in strips of 10 for convenient use. Manufactured under strict quality standards, it targets essential needs in hypertension care, making it a staple in many treatment plans across India.\n​\n\nThis medication stands out due to its triple action on L-type, N-type, and T-type calcium channels, providing broader vascular protection compared to some other blockers. Doctors prescribe it for adults dealing with persistent high blood pressure or chest pain, often starting at this 4 mg strength for balanced efficacy. Unlike generic options, BENIPRIME 4 ensures consistent absorption and formulation tailored for Indian patients, with pricing around Rs 62-89 per strip after discounts.\n​\n\nHow BENIPRIME 4 Works\nBenidipine in BENIPRIME 4 blocks calcium entry into smooth muscle cells of blood vessels and heart muscles. This action causes vasodilation, widening arteries to lower resistance and ease blood flow. By reducing systolic and diastolic pressure, it lightens the heart's workload without drastically slowing the heartbeat.\n​\n\nThe unique blockade of multiple calcium channels also boosts nitric oxide production, offering antioxidant effects and protection against artery hardening. This sustained mechanism provides 24-hour control, ideal for once-daily dosing after breakfast. Over time, it may even reduce urinary protein and triglycerides, supporting kidney and metabolic health in hypertensives.\n​\n\nKey Uses of BENIPRIME 4\nBENIPRIME 4 primarily treats essential hypertension, helping prevent strokes, heart attacks, and kidney damage. It effectively manages angina pectoris by enhancing coronary blood supply, reducing chest pain episodes during activity.\n​\n\nPhysicians also use it for renal parenchymal hypertension, where kidney issues elevate blood pressure. In emergencies like hypertensive crises or subarachnoid hemorrhage, higher doses prove beneficial, though 4mg serves as maintenance. For arrhythmia or anal fissures linked to vascular strain, it offers supportive relief.\n​\n\nLowers high blood pressure in adults, including severe cases with dose adjustments.\n​\n\nEases angina symptoms, improving exercise tolerance and daily life quality.\n​\n\nProtects renal function in proteinuric patients by stabilizing vessels.\n​\n\nDosage and Administration\nTake BENIPRIME 4 as 4 mg once daily, swallowed whole after a meal to minimize stomach upset. Doctors may adjust to 2-8mg based on response, age, or kidney/liver status, never exceeding 8 mg daily without monitoring. Consistency in timing ensures steady levels for optimal pressure control.\n​\n\nMissed doses require prompt intake if remembered soon, but skip if near the next one—avoid doubles. Pair with lifestyle changes like low-salt diets and exercise for best results. Always consult for personalization, especially in elderly or comorbid patients.\n​\n\nKey Benefits\nBENIPRIME 4 excels in long-term blood pressure reduction, with studies showing sustained drops in brachial-ankle pulse wave velocity beyond mere pressure effects. It protects the heart and kidneys through anti-sclerotic and antioxidant actions, lowering cardiovascular event risks.\n​\n\nPatients experience fewer angina attacks, better endurance, and improved quality of life. The once-daily regimen boosts adherence, while vascular selectivity minimizes reflex tachycardia common in other blockers. Clinical data indicate reduced C-reactive protein and aldosterone, curbing inflammation and fibrosis.\n​\n\nBenefit\tDescription\tSupporting Evidence\nBP Control\tReduces systolic/diastolic pressure effectively over 24 hours \n​\tLong-term studies show persistent effects post-treatment \n​\nHeart Protection\tImproves coronary flow, cuts angina frequency \n​\tMyocardial protection via NO stimulation \n​\nRenal Support\tLowers proteinuria, aids kidney hypertension \n​\tAnti-oxidative vascular benefits \n​\nAdherence Ease\tOnce-daily dosing with sustained release \n​\tHigh membrane affinity for lasting action \n​\nAdditional perks include potential triglyceride reduction and osteoblast stimulation for bone health in hypertensives.\n\nPotential Side Effects\nMost users tolerate BENIPRIME 4 well, with mild, transient effects resolving spontaneously. Common issues include headache, dizziness, flushing, ankle swelling, palpitations, fatigue, nausea, and sleepiness.\n​\n\nLess frequent are constipation, abdominal pain, tinnitus, shoulder stiffness, urinary frequency, or elevated liver enzymes. Rare serious reactions involve severe hypotension, rash, itching, or allergic responses—seek immediate care if these arise. Monitor blood pressure during initiation to avoid drops.\n\nHeart-related: Palpitations, chest pressure\n​\n\nNervous system: Dizziness, headache\n\nSkin/Vascular: Flushing, edema.\n\nGI: Nausea, constipation\n​\n\nLiver/kidney patients need caution; inform doctors of history.\n\n\nPrecautions and Interactions\nAvoid in hypotension, severe aortic stenosis, or hypersensitivity to dihydropyridines. Use cautiously in liver/kidney impairment, pregnancy, or breastfeeding—benefits must outweigh risks. Grapefruit juice may amplify effects; limit alcohol.\n​\n\nIt interacts with beta-blockers, digoxin, or CYP3A4 inhibitors like ketoconazole, potentially enhancing hypotension. Regular monitoring of BP, electrolytes, and renal function is advised during therapy. Abrupt stop may rebound pressure; taper under guidance.\n​\nConclusion\nBENIPRIME 4 with Benidipine 4 mg empowers reliable hypertension and angina control through innovative calcium channel action. Balancing potent benefits like organ protection and ease of use against manageable side effects, it fits seamlessly into modern cardiac care. Consult healthcare providers for tailored integration with lifestyle for lasting heart health. ", "price": 89.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2261, "imageuri": "https://productimages.withfloats.com/actual/6958dbfc615a7d157715572f.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6958dbfc615a7d157715572f.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-03T09:06:02.841Z", "updatedon": "2026-03-13T06:54:02.808Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/benidipine-4mg/2261", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BENIPRIME 4", "category": "CARDIOLOGYRANGE", "tags": [ "benidipine 4mg", "benidipine 4mg tab", "benidipine hydrochloride uses.", "benidipine.", "benidipine 4 mg", "benidipine 4", "benidipine maximum dose", "benidipine 4 mg uses.", "benidipine price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6954d5cbb4697f18294b1c0e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Dydrogesterone 10 mg", "description": "DABROSTON 10 is a pharmaceutical preparation containing Dydrogesterone 10 mg, a synthetic progestogen that closely mimics the natural hormone progesterone produced by the female body. Manufactured with precision and care, DABROSTON 10 represents a breakthrough in women's reproductive health management, offering a reliable and effective solution for various gynecological conditions related to progesterone deficiency.\nUnlike many other synthetic progestogens, Dydrogesterone in DABROSTON 10 has a unique molecular structure that allows it to work specifically on the uterine lining without causing unwanted androgenic or estrogenic effects. This makes it an ideal choice for women requiring hormonal support while minimizing the risk of side effects commonly associated with other progestational agents.\nDABROSTON 10 is prescribed by healthcare professionals worldwide for conditions ranging from menstrual irregularities to fertility support, endometriosis management, and prevention of miscarriage in women with a history of recurrent pregnancy loss. Its versatility and safety profile have made it a cornerstone in modern gynecological therapeutics.\nUnderstanding Dydrogesterone and Its Uses\nDydrogesterone is an orally active progestogen that was specifically developed to provide the benefits of natural progesterone without the drawbacks of traditional synthetic progestogens. When you take DABROSTON 10, the Dydrogesterone is absorbed into your bloodstream and acts on progesterone receptors throughout your body, particularly in the uterus, where it exerts its primary therapeutic effects.\nPrimary Uses of DABROSTON 10:\nMenstrual Disorders: DABROSTON 10 is highly effective in treating various menstrual irregularities, including dysmenorrhea (painful periods), irregular menstrual cycles, and secondary amenorrhea (absence of periods). By regulating the endometrial lining, it helps restore normal menstrual patterns and reduces associated discomfort.\nEndometriosis Management: For women suffering from endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, causing pain and fertility issues, DABROSTON 10 helps suppress the growth of endometrial tissue and provides significant symptom relief.\nLuteal Phase Support: During fertility treatments or for women with luteal phase defects, DABROSTON 10 provides crucial progesterone support to help prepare the uterine lining for embryo implantation and maintain early pregnancy.\nPrevention of Miscarriage: Women with a history of recurrent miscarriage due to progesterone deficiency can benefit from DABROSTON 10, which helps maintain the uterine environment necessary for pregnancy continuation.\nPremenstrual Syndrome (PMS): The hormonal imbalances that contribute to PMS symptoms can be effectively managed with DABROSTON 10, providing relief from mood swings, breast tenderness, and bloating.\nHormone Replacement Therapy (HRT): When combined with estrogen therapy in postmenopausal women, DABROSTON 10 protects the uterine lining from excessive growth (endometrial hyperplasia) that estrogen alone might cause.\nDysfunctional Uterine Bleeding: Abnormal uterine bleeding not caused by organic pathology can be controlled with DABROSTON 10 by regulating the endometrial cycle.\nKey Benefits of DABROSTON 10\n1. Natural Hormone Profile\nOne of the most significant advantages of DABROSTON 10 is its molecular similarity to natural progesterone. This means your body recognizes and processes it almost identically to the progesterone it produces naturally, resulting in better tolerance and effectiveness.\n2. Minimal Side Effects\nUnlike many synthetic progestogens that can cause masculinizing effects, weight gain, or mood disturbances, DABROSTON 10 has a remarkably clean side effect profile. It doesn't possess androgenic, estrogenic, or glucocorticoid activity, which means fewer unwanted effects on your body.\n3. Selective Progestational Activity\nDABROSTON 10 works specifically on the uterine lining where it's needed most, without significantly affecting other body systems. This targeted action makes it highly effective for gynecological conditions while maintaining safety.\n4. Oral Administration\nThe convenience of oral dosing makes DABROSTON 10 easy to incorporate into your daily routine. No injections or invasive procedures are required, and the tablets can be taken with or without food.\n5. Pregnancy Safe\nWhen prescribed appropriately, DABROSTON 10 is considered safe during pregnancy, particularly in the first trimester for women at risk of miscarriage. It doesn't harm fetal development and can be crucial in maintaining healthy pregnancies.\n6. Metabolic Neutrality\nDABROSTON 10 doesn't adversely affect lipid metabolism, glucose tolerance, or blood clotting factors in the way some other hormonal preparations might. This makes it suitable for a broader range of women, including those with metabolic concerns.\n7. Flexible Dosing\nThe 10 mg strength allows for flexible dosing regimens tailored to individual needs. Your healthcare provider can adjust the timing and duration of treatment based on your specific condition and response.\n8. Proven Efficacy\nDecades of clinical use and extensive research have established DABROSTON 10 (Dydrogesterone) as a gold standard in progestogen therapy. Its effectiveness has been demonstrated in numerous clinical trials and real-world applications.\n9. Quality of Life Improvement\nBy effectively managing hormonal imbalances and their associated symptoms, DABROSTON 10 significantly improves quality of life. Women report better sleep, improved mood, reduced pain, and enhanced overall well-being.\n10. Supports Fertility Goals\nFor women trying to conceive, DABROSTON 10 provides essential hormonal support that can make the difference between conception success and failure, particularly in cases of luteal phase deficiency or recurrent pregnancy loss.\nUnderstanding Side Effects\nWhile DABROSTON 10 is generally well-tolerated, like all medications, it may cause side effects in some individuals. Understanding these potential effects helps you make informed decisions and know when to contact your healthcare provider.\nCommon and Generally Mild Side Effects:\nHeadache: Some women experience mild to moderate headaches, particularly when first starting treatment. These typically resolve as your body adjusts to the medication.\nNausea: Mild nausea may occur, especially if taken on an empty stomach. Taking DABROSTON 10 with food can help minimize this effect.\nBreast Tenderness: Temporary breast sensitivity or tenderness is relatively common and usually subsides with continued use.\nMood Changes: Mild mood fluctuations may occur, though DABROSTON 10 is less likely to cause mood disturbances compared to other progestogens.\nDizziness: Some women report feeling slightly dizzy, particularly shortly after taking the medication.\nAbdominal Discomfort: Mild stomach discomfort or bloating may occur but is generally temporary.\nLess Common Side Effects:\nBreakthrough bleeding or spotting between periods may occur, especially during the first few cycles of treatment. Fatigue or drowsiness can affect some individuals. Skin reactions such as mild rash or itching are possible but rare. Some women may experience changes in menstrual flow pattern. Rarely, liver function changes may occur, which is why periodic monitoring may be recommended for long-term use.\nWhen to Contact Your Healthcare Provider:\nWhile serious side effects are rare with DABROSTON 10, you should contact your doctor immediately if you experience severe abdominal pain, significant mood changes or depression, jaundice (yellowing of skin or eyes), severe allergic reactions including difficulty breathing or swelling, severe or persistent headaches, visual disturbances, or unusual vaginal bleeding.\nIt's important to remember that most women taking DABROSTON 10 experience few to no side effects. The benefits of treatment typically far outweigh the potential risks, especially when the medication is used as prescribed under medical supervision.\nImportant Considerations\nNot for Everyone: DABROSTON 10 should not be used by women with known hypersensitivity to Dydrogesterone, undiagnosed vaginal bleeding, or certain liver conditions. Always inform your healthcare provider about your complete medical history.\nDrug Interactions: Certain medications may interact with DABROSTON 10, including some enzyme-inducing drugs that can reduce its effectiveness. Inform your doctor about all medications, supplements, and herbal products you're taking.\nPregnancy and Breastfeeding: While DABROSTON 10 is used to support early pregnancy, its use in later pregnancy stages should only be under medical supervision. Small amounts may pass into breast milk, so discuss with your doctor if you're breastfeeding.\nMonitoring: Depending on your condition and duration of treatment, your healthcare provider may recommend periodic check-ups and possibly liver function tests to ensure safe, continued use.\nHow to Use DABROSTON 10\nAlways take DABROSTON 10 exactly as prescribed by your healthcare provider. The dosing regimen varies depending on the condition being treated. It may be taken continuously, cyclically (certain days of your menstrual cycle), or in specific patterns for fertility support. Tablets should be swallowed whole with water and can be taken with or without food. If you miss a dose, take it as soon as you remember unless it's nearly time for your next dose. Never double up doses to make up for a missed one.\nConclusion\nDABROSTON 10 represents a significant advancement in women's reproductive health management, offering a safe, effective, and well-tolerated solution for various gynecological conditions related to progesterone deficiency. Its unique molecular structure, which closely mimics natural progesterone, sets it apart from other synthetic progestogens by providing therapeutic benefits without the unwanted androgenic effects commonly associated with hormonal treatments.", "price": 637.0, "discountamount": 191.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2258, "imageuri": "https://productimages.withfloats.com/actual/6954d5cd5542d9b6b39275fa.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6954d5cd5542d9b6b39275fa.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-31T07:50:35.025Z", "updatedon": "2026-03-12T11:33:06.791Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dydrogesterone-10-mg/2258", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DABROSTON 10", "category": "GYANECOLOGYRANGE", "tags": [ "Dydrogesterone 10 mg", "Menstrual Disorders.", "Prevention of Miscarriage.", "Premenstrual Syndrome (PMS).", "endometrial tissue proliferation outside the uterus.", "Endometriosis Management.", "hormonal treatments.", "dydrogesterone 10 mg.", "dydrogesterone 10 mg tablet uses.", "dydrogesterone 10 mg tablet uses in hindi", "dydrogesterone 10 mg tablet uses in pregnancy.", "tablet dydrogesterone 10 mg.", "dydrogesterone 10 mg in pregnancy.", "dydrogesterone 10 mg tablet price." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69316145bf2a5ce08905eadf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Temozolomide 250 mg", "description": "Temozolomide 250 mg, marketed under the brand name TMOZOLMIDE 250 by Steris Healthcare, is a potent chemotherapy drug primarily used to treat certain aggressive brain tumors such as glioblastoma multiforme (GBM) and anaplastic astrocytoma. Its mechanism of action involves alkylation of DNA, which damages the cancer cells’ DNA strands, leading to their programmed death and inhibition of tumor growth. This effect is achieved through the addition of a methyl group at the O6 and N7 positions of guanine in DNA. Tumor cells damaged by this process are unable to reproduce and eventually die, making Temozolomide an effective agent in chemotherapy regimens[,].​\n\nWhat are the benefits of temozolomide 250 mg?\nTemozolomide 250 mg offers significant benefits for patients battling brain cancers. It crosses the blood-brain barrier effectively, which allows it to reach tumor cells inside the brain where many other drugs cannot penetrate. This expands its efficacy in treating primary brain tumors and certain metastatic tumors that have spread to the brain. In clinical settings, it has been shown to improve progression-free survival rates and, in some cases, overall survival when used with radiation therapy or alone during maintenance treatment phases[,].​\n\nKey Benefits of Temozolomide 250 mg\nEffective treatment of aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma.\n\nCan be administered orally, offering convenience compared to intravenous chemotherapy.\n\nAbility to cross the blood-brain barrier, ensuring targeted therapy within the central nervous system.\n\nWell-established as part of the standard Stupp protocol (combined with radiotherapy).\n\nMay improve quality of life by slowing tumor progression and managing symptoms associated with brain tumors[,].​\n\nSide Effects of Temozolomide 250 mg\nWhile Temozolomide is effective, it may cause side effects common to chemotherapy medications due to its impact on both cancerous and healthy rapidly dividing cells.\n\nCommon Side Effects of Temozolomide 250 mg\nNausea and vomiting, which can sometimes be severe.\n\nFatigue and weakness.\n\nHair thinning or hair loss.\n\nConstipation or diarrhea.\n\nLoss of appetite.\n\nMouth sores or changes in taste.\n\nDizziness or headache.\n\nMild skin rashes or itching[,].​\n\nSerious Side Effects of Temozolomide 250 mg\nSignificant reduction in blood cell counts causing anemia, leukopenia, or thrombocytopenia (requiring close blood monitoring).\n\nSevere infections due to immune suppression.\n\nAllergic reactions, including swelling, itching, or rash.\n\nLiver dysfunction or jaundice.\n\nSeizures or neurological symptoms.\n\nUnusual bleeding or bruising.\n\nSigns of severe allergic reaction like difficulty breathing[,].​\n\nAvailable Substitute for Temozolomide 250 mg\nThere are limited direct substitutes for Temozolomide due to its unique ability to treat brain tumors crossing the blood-brain barrier. Alternatives depend on tumor type and may include other chemotherapy drugs like lomustine (CCNU), carmustine (BCNU), or newer targeted therapies and immunotherapies under clinical trial. However, these alternatives may vary in efficacy and side effect profile and are generally used under oncologist guidance[,].\n\nDosage Guidelines for Temozolomide 250 mg\nThe dosage of Temozolomide 250 mg (TMOZOLMIDE 250) by Steris Healthcare is carefully tailored based on the type and stage of cancer, body surface area (BSA), and patient tolerance. The standard regimen for newly diagnosed glioblastoma is an oral dose of 75 mg/m² daily during radiotherapy, followed by maintenance cycles of 150 to 200 mg/m² for 5 days every 28 days. Dose adjustments are common based on blood counts and side effects. Strict adherence to the prescribed dosage schedule and monitoring are critical for safety and efficacy.", "price": 12187.0, "discountamount": 3657.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2229, "imageuri": "https://productimages.withfloats.com/actual/693161477743cf6a1359d094.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/693161477743cf6a1359d094.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-04T10:24:05.165Z", "updatedon": "2026-03-12T08:08:17.975Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//temozolomide-250-mg/2229", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TMOZOLMIDE 250", "category": "Oncology", "tags": [ "Temozolomide 250 mg", "cancer", "brain tumors", "cancer cells", "Tumor cells", "chemotherapy", "TMOZOLMIDE 250", "Temozolomide 250 mg capsule uses", "How to take Temozolomide 250 mg correctly", "Temozolomide 250 mg dosage schedule guide", "Temozolomide 250 mg dosage schedule guide", "Temozolomide 250 mg for glioblastoma treatment", "Temozolomide 250 mg empty stomach instructions", "What is Temozolomide 250 mg prescribed for", "Temozolomide 250 mg chemotherapy cycle details", "Temozolomide 250 mg patient information leaflet", "Temozolomide 250 mg storage instructions", "Temozolomide 250 mg manufacturer price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891f38987594971b42f56f7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Citicoline and piracetam tablets", "description": "CITICOTIME PM is a clinically advanced neuroprotective tablet that combines two well-researched components: Citicoline 500mg and Piracetam 800mg. This powerful formulation is tailored to support brain function and facilitate neurological recovery, particularly beneficial for patients recovering from strokes or dealing with cognitive issues. Citicoline enhances brain metabolism and aids in nerve cell membrane repair, while Piracetam improves neural communication and boosts neuroplasticity. Together, they offer a comprehensive approach to protecting and enhancing brain health. CITICOTIME PM is ideal for patients undergoing neurorehabilitation or looking to manage memory and cognitive deterioration as part of a prescribed regimen.\n\nWhat Are Citicoline and Piracetam Tablets?\nCITICOTIME PM delivers Citicoline and Piracetam in tablet form, with each dose containing 500mg of Citicoline and 800mg of Piracetam. Citicoline supports the repair of damaged neurons and strengthens cell membrane integrity, while Piracetam stimulates neurotransmission, enhances memory and attention, and promotes cognitive function. This combination works synergistically to facilitate brain recovery following neurological injuries such as strokes.\n\nUses of Citicoline and Piracetam Tablets\nAssists in post-stroke treatment and neurological rehabilitation\n\nPrescribed for memory loss or age-related cognitive impairment\n\nBeneficial for patients with Alzheimer's disease, vascular dementia, or mild cognitive decline\n\nSupports recovery after traumatic brain injuries\n\nPromotes neuroregeneration and cognitive health\n\nDosage Guidelines\nThe standard recommended dose of CITICOTIME PM is one tablet daily or twice daily, as directed by your healthcare provider. Dosage may vary depending on the patient’s condition, tolerance level, and medical history. Always follow your doctor's advice for the safest and most effective results.\n\nPossible Side Effects\nWhile CITICOTIME PM is generally well-tolerated, some individuals may experience side effects such as:\n\nHeadaches\n\nDifficulty sleeping (insomnia)\n\nNausea or digestive discomfort\n\nIrritability or restlessness\n\nDizziness\n\nSkin rashes or allergic reactions (rare)\n\nSlight increase in blood pressure (rare)\n\nIf symptoms persist or worsen, consult a medical professional promptly.\n\nPrecautions Before Use\nBefore starting CITICOTIME PM, let your doctor know if you:\n\nHave any known allergies to Citicoline, Piracetam, or related drugs\n\nSuffer from kidney or liver disorders, bleeding problems, or psychiatric conditions\n\nAre pregnant, planning to become pregnant, or breastfeeding\n\nAre elderly or managing chronic health conditions\n\nAre consuming alcohol or other CNS depressants\n\nDrug Interactions\nCITICOTIME PM may interact with certain medications, including:\n\nBlood thinners (e.g., warfarin) – may increase bleeding risk\n\nCNS stimulants – may intensify neurological effects\n\nAntiepileptics (e.g., phenytoin, carbamazepine) – may require dose adjustments\n\nAlways inform your physician of all medications and supplements you are using to avoid potential adverse interactions.\n\nConclusion\nCITICOTIME PM is a scientifically backed formulation combining Citicoline 500mg and Piracetam 800mg, aimed at enhancing cognitive abilities and supporting neurological recovery. It’s particularly effective in post-stroke management, age-related memory loss, and other cognitive impairments. With proper medical supervision, this combination offers significant improvement in focus, memory, and brain performance. Always follow your doctor’s recommendations for optimal safety and benefits.", "price": 495.94, "discountamount": 148.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2157, "imageuri": "https://productimages.withfloats.com/actual/6918295077058844db074caa.png", "tileimageuri": "https://productimages.withfloats.com/tile/6918295077058844db074caa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:05:29.796Z", "updatedon": "2026-05-23T07:24:32.668Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//citicoline-and-piracetam-tablets/2157", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CITICOTIME PM", "category": "NEUROLOGY RANGE", "tags": [ "citicoline and piracetam tablets", "citicoline piracetam tablet uses", "citicoline piracetam tablets benefits", "citicoline piracetam tablets dosage", "citicoline piracetam tablets side effects", "citicoline piracetam tablets composition", "what is citicoline and piracetam tablet used for", "citicoline piracetam tablets for brain health", "citicoline piracetam tablets for memory improvement", "citicoline piracetam tablets for stroke recovery", "citicoline piracetam tablets for cognitive enhancement", "citicoline piracetam tablets mechanism of action", "citicoline piracetam tablets for dementia", "citicoline piracetam tablets for alzheimer patients", "citicoline piracetam tablets for neurological disorders", "citicoline piracetam tablets for brain injury", "citicoline piracetam tablets for vertigo", "best citicoline piracetam tablets in india", "citicoline piracetam tablets price", "citicoline piracetam tablets manufacturer", "citicoline piracetam tablets supplier india", "citicoline piracetam tablets wholesale", "citicoline piracetam tablets pharma company", "is citicoline and piracetam tablet safe", "how to take citicoline piracetam tablets", "citicoline piracetam tablets long term use", "brain tonic tablets citicoline piracetam" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ae5c5ca84cd189c25cbff", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "rasagiline 0.5 mg", "description": "Rasagail 0.5 \nRasagiline (0.5mg)\nIntroduction:\n\nRasagail 0.5 encapsulates the medicinal prowess of Rasagiline, a potent and selective monoamine oxidase-B (MAO-B) inhibitor used in the management of Parkinson's disease. With a dosage strength of 0.5mg, Rasagail 0.5 aims to optimize neurological function and enhance quality of life for individuals battling Parkinson's disease.\nKey Features and Benefits:\nMAO-B Inhibition:\nRasagail 0.5 exerts its therapeutic effects by selectively inhibiting MAO-B enzymes, thereby increasing dopamine levels in the brain's striatum. This mechanism helps alleviate motor symptoms and improve motor function in Parkinson's disease.\nNeuroprotective Properties:\n\nBeyond symptomatic relief, Rasagail 0.5 offers neuroprotective benefits by reducing oxidative stress, preventing neuronal damage, and potentially slowing disease progression in Parkinson's patients.\nEnhanced Dopaminergic Transmission:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 0.5 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and independence.\nAdjunctive Therapy:\n\nRasagail 0.5 can be used as monotherapy in early-stage Parkinson's disease or as an adjunct to levodopa/carbidopa in advanced stages, providing a comprehensive approach to symptom management.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 0.5 is 0.5mg once daily, taken orally with or without food. Dosage adjustments may be made based on individual patient response and tolerability.\nTitration and Maintenance:\nGradual titration may occur as directed by healthcare providers to achieve optimal therapeutic benefits while minimizing side effects. Maintenance doses are typically tailored to individual patient needs.\nContinued Monitoring:\nRegular clinical assessments and monitoring of Parkinson's disease symptoms, motor function, and potential adverse effects are essential components of Rasagail 0.5 therapy to ensure treatment efficacy and safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 70.0, "discountamount": 2.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "life", "EMAIL", "Order", "0.5mg", "brain", "safety", "tremors", "quality", "striatum", "rigidity", "patients", "carbidopa", "mechanism", "Rasagiline", "monotherapy", "information", "individuals", "Introduction", "sterisonline", "Key Features", "bradykinesia", "independence", "side effects", "tolerability", "sterispharma", "CALL/WHATSAPP", "MAO-B enzymes", "starting dose", "Administration", "Initial Dosage", "motor function", "motor symptoms", "dopamine levels", "dosage strength", "neuronal damage", "advanced stages", "MAO-B) inhibitor", "oxidative stress", "greater mobility", "MAO-B Inhibition", "disease symptoms", "Maintenance doses", "medicinal prowess", "Gradual titration", "Adjunctive Therapy", "symptom management", "Dosage adjustments", "treatment efficacy", "symptomatic relief", "therapeutic effects", "disease progression", "essential components", "healthcare providers", "Rasagail 0.5 therapy", "Continued Monitoring", "neurological function", "early-stage Parkinson", "comprehensive approach", "neuroprotective benefits", "individual patient needs", "potential adverse effects", "Neuroprotective Properties", "individual patient response", "smoother motor coordination", "optimal therapeutic benefits", "Regular clinical assessments", "selective monoamine oxidase-B", "dopaminergic neurotransmission", "Enhanced Dopaminergic Transmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1887, "imageuri": "https://productimages.withfloats.com/actual/666ae5c88c6c791fd3b65cab.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae5c88c6c791fd3b65cab.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:27:49.832Z", "updatedon": "2026-03-12T11:26:27.451Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rasagiline-0-5-mg/1887", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rasagail 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "rasagiline side effects", "rasagiline benefits", "long-term side effects of rasagiline", "rasagiline uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666abe06cee93a1bbc383645", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "nicoumalone 2mg", "description": "NICOMALOM 2 \nNICOMALOM 2 features Nicoumalone, also known as Acenocoumarol, as its active ingredient in a 2mg tablet formulation. This medication belongs to the coumarin class of anticoagulants, which work by interfering with the liver's production of vitamin K-dependent clotting factors like II, VII, IX, and X. Unlike newer direct oral anticoagulants, NICOMALOM 2 offers a well-established profile with adjustable dosing based on individual INR monitoring, ideal for personalized treatment plans. Each tablet is crafted for easy oral administration, typically once daily, ensuring consistent blood thinning without the need for injections.\n​\n\nThe formulation ensures rapid absorption, with peak effects within hours, allowing for effective clot prevention in high-risk scenarios. Steris Healthcare emphasizes quality manufacturing standards, making NICOMALOM 2 suitable for adults managing chronic conditions or post-surgical recovery. Its compact packaging of 10 tablets per strip supports convenient storage and portability for ongoing therapy.\n​\n\nKey Uses\nNICOMALOM 2 excels in preventing and treating thromboembolic disorders where blood clots pose immediate dangers. Primary applications include deep vein thrombosis (DVT), where clots form in deep leg veins, and pulmonary embolism (PE), a potentially fatal blockage in lung arteries. Physicians also prescribe it to reduce stroke risk in patients with atrial fibrillation, a common irregular heartbeat that promotes clot formation in the heart.\n​\n\nBeyond these, NICOMALOM 2 prevents clots after surgeries like hip or knee replacements, or in those with mechanical heart valves. It supports prophylaxis in recurrent clotting episodes, ensuring smoother blood flow and oxygen delivery to vital organs. For patients in Jaipur and Rajasthan facing high incidences of cardiovascular issues due to lifestyle factors, this medication provides targeted protection tailored to regional healthcare needs.\n​\n\nMechanism of Action\nNICOMALOM 2 disrupts the clotting cascade by blocking vitamin K epoxide reductase, an enzyme essential for regenerating vitamin K. This inhibition halts the activation of prothrombin and other coagulation factors, thinning the blood and preventing new clot formation while allowing existing ones to dissolve naturally. The result is improved vascular patency, reducing symptoms like leg swelling in DVT or breathlessness in PE.\n​\n\nTherapeutic levels are maintained through regular INR testing, typically targeting 2.0-3.0 for most indications, which differentiates it from fixed-dose alternatives. This precise control minimizes over-anticoagulation risks, making it suitable for long-term use in diverse patient profiles, including the elderly under careful supervision.\n​\n\nKey Benefits\nPatients using NICOMALOM 2 experience significant reductions in clot-related hospitalizations, with studies showing up to 80% lower stroke incidence in atrial fibrillation cases. Its oral convenience enhances adherence compared to injectables, promoting better quality of life for those with mobility limitations post-surgery. Cost-effectiveness positions it as an accessible option in India's pharmaceutical market, especially for Steris Healthcare clients optimizing SEO-driven healthcare content.\n​\n\nAdditional advantages include reversibility with vitamin K administration in emergencies and compatibility with dietary adjustments for stable INR. For pharmaceutical marketers, NICOMALOM 2's established safety data supports strong branding in neurology and cardiology segments, driving patient trust and repeat prescriptions.\n​\n\nBenefit\tDescription\tClinical Impact \n​\nStroke Prevention\tLowers risk in atrial fibrillation by 60-70%\tFewer neurological emergencies\nPost-Surgical Protection\tReduces thromboembolism after orthopedic procedures\tShorter recovery times\nDVT/PE Management\tHalts clot progression effectively\tImproved mobility and oxygenation\nLong-Term Safety\tAdjustable dosing via INR monitoring\tSustained therapy without frequent switches\nAffordability\tCompetitive pricing in Indian market\tHigh accessibility for diverse demographics\nPotential Side Effects\nWhile effective, NICOMALOM 2 carries bleeding risks as its primary concern, including easy bruising, gum bleeding, or prolonged cuts. Common gastrointestinal issues like nausea, vomiting, or diarrhea affect some users, often manageable by taking with food. Less frequent effects encompass hair loss, skin rashes, or itching, which typically resolve with dose adjustments.\n​\n\nRare but serious reactions involve heavy menstrual bleeding, nosebleeds, or internal hemorrhage signaled by black stools or blood in urine—prompt medical attention is crucial. Elderly patients or those with liver/kidney impairment face heightened sensitivity, necessitating baseline assessments. Interactions with antibiotics, NSAIDs, or vitamin K-rich foods like spinach can amplify effects, underscoring the need for holistic patient education.\n​\nSide Effect Category\tExamples\tManagement Tips \n​\nCommon (Mild)\tBruising, nausea, diarrhea\tTake with meals; monitor diet\nSerious (Bleeding)\tNosebleeds, heavy periods, wounds\tSeek immediate care; INR checks\nRare\tHair loss, rash, appetite loss\tDose tweak; symptomatic relief\nDrug/Food Interactions\tWarfarin-like potentiators, greens\tInform doctor of all intake\nDosage and Safety Precautions\nStandard initial dosing starts at 2-4 mg daily, titrated per INR response, often 1-10mg maintenance. Children and the elderly require caution with lower starts. Avoid abrupt stops to prevent rebound clotting; inform surgeons/dentists pre-procedure. Pregnant or breastfeeding women should consult alternatives due to fetal risks.\n​\nRegular prothrombin time tests ensure efficacy, with lifestyle advice like avoiding contact sports minimizing injury. Store at room temperature, away from moisture.\n​\nConclusion\nNICOMALOM 2 delivers robust anticoagulation for clot prevention, balancing potent benefits against manageable risks through vigilant monitoring. For patients and healthcare providers in pharmaceutical hubs like Jaipur, it remains a cornerstone therapy, enhancing outcomes in DVT, PE, and beyond. Always prioritize professional guidance for optimal results.", "price": 227.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "2 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1860, "imageuri": "https://productimages.withfloats.com/actual/666abe098b71a2cb2d7d3c68.png", "tileimageuri": "https://productimages.withfloats.com/tile/666abe098b71a2cb2d7d3c68.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:38:14.673Z", "updatedon": "2026-03-13T05:57:23.788Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nicoumalone-2mg/1860", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 2 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 2mg uses", "nicoumalone tablet", "nicoumalone tablets side effects", "nicoumalone tablet dosage", "nicoumalone drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665efc4cea22b014e8af0117", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Teneligliptin 20mg & Dapagliflozin Propanediol Monohydrate 5mg", "description": "GLIDAPA TENE 5/20 \nTeneligliptin 20mg & Dapagliflozin Propanediol Monohydrate 5mg\nIntroduction\nGLIDAPA TENE 5/20 is an advanced combination medication tailored for the management of Type 2 diabetes. This oral formulation brings together Teneligliptin (20 mg) and Dapagliflozin Propanediol Monohydrate (5 mg), optimizing glucose control through dual mechanisms of action.\n\nHow It Works\n\nTeneligliptin (20 mg): As a DPP-4 inhibitor, Teneligliptin enhances the body’s natural insulin response after meals. It works by prolonging the activity of incretin hormones, which increase insulin release and decrease glucagon production, particularly post-prandially. This results in a reduction of blood glucose spikes.\nDapagliflozin Propanediol Monohydrate (5 mg): Functioning as an SGLT2 inhibitor, Dapagliflozin helps the kidneys eliminate glucose from the bloodstream through the urine. This not only lowers blood sugar levels but also assists in weight management and may have cardiovascular benefits.\nBenefits\nThe combination of Teneligliptin and Dapagliflozin in GLIDAPA TENE 5/20 offers a potent therapeutic approach by attacking diabetes on two fronts. This enhances glycemic control, reduces the risk of hypoglycemia compared to other therapies, and can contribute to weight loss — a beneficial side effect for many individuals with Type 2 diabetes.\n\nDosage and Administration\n\nDosage: Typically prescribed as one tablet per day, the dosage may need adjustments based on individual efficacy and tolerability.\nAdministration: GLIDAPA TENE 5/20 should be taken in the morning, with or without food. Consistency in the timing of dosage is crucial for maintaining steady drug levels and optimizing effectiveness.\nSide Effects\nCommon side effects include urinary tract infections and genital infections due to increased sugar in urine, and potential gastrointestinal issues like nausea. Dehydration is a risk factor due to the diuretic effect of Dapagliflozin, making it important for patients to maintain adequate hydration.\n\nConclusion\nGLIDAPA TENE 5/20 represents a significant advancement in the treatment of Type 2 diabetes, combining two effective drugs that provide complementary actions to improve blood sugar control. This combination can simplify the treatment regimen, enhance patient adherence, and lead to better overall management of diabetes. Patients should engage closely with their healthcare providers to tailor the treatment plan to their specific needs and monitor their health closely to optimize outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-tene-5-20-134232", "price": 225.0, "discountamount": 67.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "body", "food", "Order", "meals", "EMAIL", "urine", "timing", "nausea", "kidneys", "morning", "outcomes", "activity", "patients", "reduction", "one tablet", "two fronts", "Conclusion", "weight loss", "information", "Dehydration", "adjustments", "risk factor", "Consistency", "bloodstream", "sterispharma", "hypoglycemia", "Introduction", "sterisonline", "tolerability", "glidapa-tene", "GLIDAPA TENE", "effectiveness", "CALL/WHATSAPP", "Teneligliptin", "specific needs", "treatment plan", "other therapies", "SGLT2 inhibitor", "DPP-4 inhibitor", "dual mechanisms", "insulin release", "Type 2 diabetes", "glucose control", "diuretic effect", "glycemic control", "oral formulation", "many individuals", "weight management", "incretin hormones", "treatment regimen", "patient adherence", "overall management", "steady drug levels", "genital infections", "adequate hydration", "blood sugar levels", "blood sugar control", "individual efficacy", "Common side effects", "two effective drugs", "glucagon production", "blood glucose spikes", "healthcare providers", "Administration Dosage", "complementary actions", "beneficial side effect", "cardiovascular benefits", "significant advancement", "urinary tract infections", "natural insulin response", "potent therapeutic approach", "advanced combination medication", "potential gastrointestinal issues", "Dapagliflozin Propanediol Monohydrate" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1299, "imageuri": "https://productimages.withfloats.com/actual/665efc4dd93d0ca61a49878b.png", "tileimageuri": "https://productimages.withfloats.com/tile/665efc4dd93d0ca61a49878b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:36:44.342Z", "updatedon": "2026-03-13T10:44:32.625Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligliptin-20mg-dapagliflozin-propanediol-monohydrate-5mg/1299", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA TENE 5/20 ", "category": "DIABETIC RANGE", "tags": [ "Teneligliptin 20mg & Dapagliflozin Propanediol Monohydrate 5mg", "teneligliptin 20 mg dapagliflozin 5 mg tablets uses", "teneligliptin dapagliflozin combination benefits for diabetes", "teneligliptin dapagliflozin tablet dosage guide", "teneligliptin dapagliflozin tablets how it works for blood sugar", "teneligliptin dapagliflozin tablet side effects in diabetes patients", "teneligliptin dapagliflozin tablets for uncontrolled diabetes" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662ba238e68e121fa8860c41", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TMOZOLMIDE 250 ", "description": "TMOZOLMIDE 250 \nTemozolomide 250 mg, marketed under the brand name TMOZOLMIDE 250 by Steris Healthcare, is a potent chemotherapy drug primarily used to treat certain aggressive brain tumors such as glioblastoma multiforme (GBM) and anaplastic astrocytoma. Its mechanism of action involves alkylation of DNA, which damages the cancer cells’ DNA strands, leading to their programmed death and inhibition of tumor growth. This effect is achieved through the addition of a methyl group at the O6 and N7 positions of guanine in DNA. Tumor cells damaged by this process are unable to reproduce and eventually die, making Temozolomide an effective agent in chemotherapy regimens[,].​\n\nWhat are the Benefits of Temozolomide 250 mg?\nTemozolomide 250 mg offers significant benefits for patients battling brain cancers. It crosses the blood-brain barrier effectively, which allows it to reach tumor cells inside the brain where many other drugs cannot penetrate. This expands its efficacy in treating primary brain tumors and certain metastatic tumors that have spread to the brain. In clinical settings, it has been shown to improve progression-free survival rates and, in some cases, overall survival when used with radiation therapy or alone during maintenance treatment phases[,].​\n\nKey Benefits of Temozolomide 250 mg\nEffective treatment of aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma.\n\nCan be administered orally, offering convenience compared to intravenous chemotherapy.\n\nAbility to cross the blood-brain barrier ensuring targeted therapy within the central nervous system.\n\nWell-established as part of the standard Stupp protocol (combined with radiotherapy).\n\nMay improve quality of life by slowing tumor progression and managing symptoms associated with brain tumors[,].​\n\nSide Effects of Temozolomide 250 mg\nWhile Temozolomide is effective, it may cause side effects common to chemotherapy medications due to its impact on both cancerous and healthy rapidly dividing cells.\n\nCommon Side Effects of Temozolomide 250 mg\nNausea and vomiting, which can sometimes be severe.\n\nFatigue and weakness.\n\nHair thinning or hair loss.\n\nConstipation or diarrhea.\n\nLoss of appetite.\n\nMouth sores or changes in taste.\n\nDizziness or headache.\n\nMild skin rashes or itching[,].​\n\nSerious Side Effects of Temozolomide 250 mg\nSignificant reduction in blood cell counts causing anemia, leukopenia, or thrombocytopenia (requiring close blood monitoring).\n\nSevere infections due to immune suppression.\n\nAllergic reactions including swelling, itching, or rash.\n\nLiver dysfunction or jaundice.\n\nSeizures or neurological symptoms.\n\nUnusual bleeding or bruising.\n\nSigns of severe allergic reaction like difficulty breathing[,].​\n\nAvailable Substitute for Temozolomide 250 mg\nThere are limited direct substitutes for Temozolomide due to its unique ability to treat brain tumors crossing the blood-brain barrier. Alternatives depend on tumor type and may include other chemotherapy drugs like lomustine (CCNU), carmustine (BCNU), or newer targeted therapies and immunotherapies under clinical trial. However, these alternatives may vary in efficacy and side effect profile and are generally used under oncologist guidance[,].\n\nDosage Guidelines for Temozolomide 250 mg\nThe dosage of Temozolomide 250 mg (TMOZOLMIDE 250) by Steris Healthcare is carefully tailored based on the type and stage of cancer, body surface area (BSA), and patient tolerance. The standard regimen for newly diagnosed glioblastoma is an oral dose of 75 mg/m² daily during radiotherapy, followed by maintenance cycles of 150 to 200 mg/m² for 5 days every 28 days. Dose adjustments are common based on blood counts and side effects. Strict adherence to the prescribed dosage schedule and monitoring are critical for safety and efficacy[,]\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 13000.0, "discountamount": 3900.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "usage", "250 mg", "nausea", "fatigue", "dosages", "adherence", "management", "TMOZOLMIDE", "Temozolomide", "crucial role", "brain tumors", "vital medication", "cancer treatment", "oral chemotherapy", "blood cell counts", "careful monitoring", "cancer cell growth", "medical supervision", "potential side effects", "glioblastoma multiforme", "aggressive brain cancers" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 774, "imageuri": "https://productimages.withfloats.com/actual/662ba23b6b24b5f9e49ac624.png", "tileimageuri": "https://productimages.withfloats.com/tile/662ba23b6b24b5f9e49ac624.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:46:48.896Z", "updatedon": "2026-03-12T08:07:56.663Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tmozolmide-250-/774", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Temozolomide (250 mg)", "category": "NEPHROLOGYRANGE", "tags": [ "Temozolomide 250 mg", "Tumor cells", "brain cancers.", "brain tumors", "tumors" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662ba161f7fe09029cbf518e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Temozolomide 100mg", "description": "TMOZOLMIDE 100\nTemodal 100mg Capsule stands as a cornerstone in oncology, specifically formulated with temozolomide 100mg to combat aggressive brain tumors like glioblastoma multiforme (GBM) and anaplastic astrocytoma. This oral alkylating agent crosses the blood-brain barrier effectively, delivering targeted chemotherapy that disrupts cancer cell DNA replication, halting tumor progression in adults with newly diagnosed or recurrent cases. Patients and caregivers often seek Temodal 100mg for its role in standard-of-care regimens, combining seamlessly with radiotherapy for enhanced survival outcomes in high-grade gliomas.​\n\nManufactured to rigorous standards, Temodal 100mg offers convenient capsule dosing, swallowed whole on an empty stomach to maximize bioavailability. Its proven track record in clinical settings makes it indispensable for neuro-oncology, where timely intervention can extend quality life years amid challenging diagnoses.​\n\nProduct Uses and Mechanism of Action\nTemodal 100mg Capsule primarily treats adult patients with newly diagnosed glioblastoma multiforme alongside radiotherapy, followed by maintenance monotherapy to prevent relapse. It also addresses refractory anaplastic astrocytoma—tumors that progress despite prior therapies—and recurrent malignant gliomas in children over three years, including brainstem glioma and high-grade astrocytoma.​\n\nThe mechanism hinges on temozolomide's rapid conversion to the active metabolite MTIC (5-(3-methyltriazen-1-yl)imidazole-4-carboxamide) at physiological pH, which methylates DNA at O6 and N7 guanine positions. This methylation induces DNA strand breaks during replication, triggering apoptosis in rapidly dividing glioma cells while sparing normal brain tissue to a degree. Unlike intravenous chemotherapies, Temodal 100mg achieves therapeutic CNS concentrations without specialized delivery, ideal for outpatient management.​\n\nIn practice, concomitant phase dosing (75 mg/m² daily with RT for 42 days) transitions to cycles of 150-200 mg/m² on days 1-5 every 28 days, tailored by body surface area and toxicity monitoring. This cyclical approach balances efficacy against cumulative myelosuppression, supporting long-term tumor control.​\n\nKey Benefits of Temodal 100mg Capsule\nTemodal 100mg delivers transformative benefits grounded in landmark trials:\n\nSuperior Survival in GBM: Concomitant temozolomide with RT extends median survival from 12.1 to 14.6 months, with 2-year survival rising from 10% to 26% per pivotal Phase III data.​\n\nMaintenance Therapy Efficacy: Post-RT cycles sustain progression-free survival up to 6-12 months in responders, delaying recurrence in MGMT-methylated tumors.​\n\nConvenient Oral Administration: Eliminates hospital visits, improving compliance for patients undergoing radiotherapy; rapid absorption (peak in 1 hour) ensures consistent exposure.​\n\nBlood-Brain Barrier Penetration: Achieves 30-40% cerebrospinal fluid levels, outperforming many alkylators in CNS malignancies.​\n\nPediatric Applicability: Effective in recurrent pediatric gliomas, with tolerance mirroring adults for ages 3+.​\n\nThese advantages position Temodal 100mg as a first-line essential, particularly for newly diagnosed cases where every month counts toward preserving cognitive function and independence.​\n\nReal-world use extends to off-label scenarios like metastatic melanoma or high-risk meningiomas under specialist oversight, though primary indications remain brain tumors. Its stability in acidic environments enhances reliability during storage and transit.​\n\nSide Effects of Temodal 100mg Capsule\nWhile Temodal 100mg offers life-prolonging potential, its myelotoxic profile demands vigilant hematologic monitoring. Common effects stem from DNA damage in rapidly proliferating bone marrow cells, peaking mid-cycle.​\n\nCommon Side Effects\nHematologic Toxicity: Neutropenia, thrombocytopenia (platelet nadir day 21-28), lymphopenia, and anemia affect 10-20%; febrile neutropenia occurs in vulnerable patients.​\n\nGastrointestinal Issues: Nausea (up to 50%), vomiting, constipation—mitigated by antiemetics like ondansetron taken 30 minutes prior.​\n\nNeurologic Symptoms: Fatigue, headache, ataxia, dizziness, or amnesia-like effects, often transient and RT-attributable.​\n\nOther: Alopecia, anorexia, rash, or elevated liver enzymes resolving post-cycle.​\n\nProphylactic measures like dose delays (if platelets <100 x 10⁹/L or neutrophils <1.5 x 10⁹/L) maintain tolerability; supportive care ensures most complete therapy.​\n\nSerious Side Effects\nRare but critical risks include:\n\nPancytopenia or Aplastic Anemia: Prolonged suppression risking infections or bleeding—mandatory weekly CBCs in early cycles.​\n\nSecondary Malignancies: Myeloid leukemia post-treatment (latency 1-5 years), hepatitis B reactivation.​\n\nOpportunistic Infections: Pneumocystis jirovecii pneumonia (PJP) prophylaxis with TMP-SMX recommended due to grade 3/4 lymphopenia.​\n\nNeurologic Deterioration: Status epilepticus, hemiplegia in advanced disease.​\n\nDiscontinue if non-hematologic CTC grade >2 persists; pregnant women face fetal toxicity—use contraception during and 6 months post-therapy.​\n\nDosage and Administration Guidelines\nInitiate Temodal 100mg at 75 mg/m² daily during RT (up to 49 days), escalating to 150 mg/m² (cycle 1) or 200 mg/m² (subsequent) for 5 days/23 off. Adjust downward for toxicity; hepatic/renal impairment rarely necessitates change unless severe. Capsules (5,20,100,250mg strengths) enable precise BSA-based dosing—e.g., ~100mg capsule for 70kg/m² patients.​\n\nPrecautions and Substitutes\nMonitor pregnancy status; avoid live vaccines. Substitutes include generic temozolomide capsules matching bioequivalence, though Temodal 100mg remains the reference standard. Interactions with valproic acid reduce clearance—increase dose 40% if co-administered.​\n\nConclusion\nTemodal 100mg Capsule empowers patients against glioblastoma's relentless advance, blending potent antineoplastic action with manageable administration for meaningful survival gains. From halting tumor growth via strategic DNA alkylation to fitting seamlessly into multimodal care, it embodies hope amid adversity—always under oncologist guidance to navigate toxicities and optimize outcomes. Embrace informed treatment; lives extend beyond statistics with vigilant care.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 7400.0, "discountamount": 2220.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "body", "types", "drugs", "class", "nausea", "spread", "growth", "surgery", "fatigue", "vomiting", "capsules", "TMOZOLMIDE", "instructions", "Temozolomide", "cancer cells", "brain tumors", "glioblastoma", "unusual symptoms", "potent medication", "other medications", "radiation therapy", "blood cell counts", "healthcare provider", "Common side effects", "comprehensive treatment plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 773, "imageuri": "https://productimages.withfloats.com/actual/662ba164481840e7a7fdadc0.png", "tileimageuri": "https://productimages.withfloats.com/tile/662ba164481840e7a7fdadc0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:43:13.957Z", "updatedon": "2026-03-12T08:07:02.773Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//temozolomide-100mg/773", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TMOZOLMIDE 100", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }